Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...

Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...

PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...

Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...

Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...

Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...

Brookstone Capital Management increased its stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by ...

Moody National Bank Trust Division grew its stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by ...